Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system
- 20 February 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 413 (2-3) , 227-234
- https://doi.org/10.1016/s0014-2999(01)00766-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in ratsEuropean Journal of Pharmacology, 1999
- CB1 cannabinoid receptor agonist WIN 55, 212-2 decreases intravenous cocaine self-administration in ratsBehavioural Brain Research, 1999
- A novel method for self-administering addicting drugs intracerebroventricularly in a free-choice procedure.Brain Research Protocols, 1998
- Δ-9-Tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the ratLife Sciences, 1997
- Δ9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptorsNeuroscience Letters, 1997
- Marijuana's interaction with brain reward systems: Update 1991Pharmacology Biochemistry and Behavior, 1991
- Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysisPsychopharmacology, 1990
- Facilitation of brain stimulation reward byΔ 9-tetrahydrocannabinolPsychopharmacology, 1988
- Intracerebroventricular self-injection of morphine in response to pain in the ratPain, 1982
- Reluctance of rats to drink hashish suspensions: Free-choice and forced consumption, and the effects of hypothalamic stimulationPsychopharmacology, 1974